Concepedia

Peter E. Lipsky

PE

Statistics

Publications

427

Citations

49.7K

H-Index

110

Active since

1973

Affiliations

The University of Texas Southwestern Medical Center(Current)

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institutes of Health

Ampel BioSolutions (United States)

University of Texas Health Science Center at Dallas

Peter E. Lipsky is an author at The University of Texas Southwestern Medical Center specializing in life sciences, immunology, and cell biology.

ORCID

Publications per year

1973–2024

427

Publications

427

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair et al. · New England Journal of Medicine · 2000 · 3K citations · Full text

, , +14

Cyclooxygenase in biology and disease

Raymond N. DuBois, Steven B. Abramson, Leslie J. Crofford et al. · The FASEB Journal · 1998 · 2.5K citations

, , +9

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld et al. · The Lancet · 1999 · 2.4K citations

, , +17

Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation

Sheng Chen, Shun‐le Chen, Peter E. Lipsky · The Journal of Immunology · 2007 · 1.1K citations · Full text

, , +17

Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis

Lee S. Simon, Arthur L. Weaver, David Y. Graham et al. · JAMA · 1999 · 804 citations

, , +17

1–5 of 427